Our eSTAR interface is changing the game on FDA 510(k) submissions

Discover More

Our eSTAR interface is changing the game on FDA 510(k) submissions

Discover More

Our eSTAR interface is changing the game on FDA 510(k) submissions

Discover More

Our eSTAR interface is changing the game on FDA 510(k) submissions

Discover More

Essenvia Insights

MedTech regulatory news and features that showcase must-know info from industry's top movers and shakers

Essenvia Insights

MedTech regulatory news and features that showcase must-know info from industry's top movers and shakers

Essenvia Insights

MedTech regulatory news and features that showcase must-know info from industry's top movers and shakers

Essenvia Insights

MedTech regulatory news and features that showcase must-know info from industry's top movers and shakers

Shawn M. Schmitt

Jul 2, 2024

Essenvia Insights: Collisions Are Inevitable at the Crossroads of MedTech Regulation and Device Innovation. Exhibit A: EU’s MDR Fender Bender (Part 2 of 2)

EU

FDA

Shawn M. Schmitt

Jun 24, 2024

Essenvia Insights: ‘Checkpoints’ or ‘Obstacles’? For Device Innovation, MedTech Regulation Can be Friend and Foe (Part 1 of 2)

Regulatory Operations

FDA

Shawn M. Schmitt

Jun 18, 2024

Essenvia Insights: 8 Expert Tips for Cleaning Up SOPs Before FDA’s QMSR Reg Takes Effect (Part 2 of 2)

FDA

QMSR

Shawn M. Schmitt

Jun 11, 2024

Essenvia Insights: 8 Expert Tips for Cleaning Up SOPs Before FDA’s QMSR Reg Takes Effect (Part 1 of 2)

FDA

QMSR

Shawn M. Schmitt

Jul 2, 2024

Essenvia Insights: Collisions Are Inevitable at the Crossroads of MedTech Regulation and Device Innovation. Exhibit A: EU’s MDR Fender Bender (Part 2 of 2)

EU

FDA

Shawn M. Schmitt

Jun 24, 2024

Essenvia Insights: ‘Checkpoints’ or ‘Obstacles’? For Device Innovation, MedTech Regulation Can be Friend and Foe (Part 1 of 2)

Regulatory Operations

FDA

Shawn M. Schmitt

Jun 18, 2024

Essenvia Insights: 8 Expert Tips for Cleaning Up SOPs Before FDA’s QMSR Reg Takes Effect (Part 2 of 2)

FDA

QMSR

Shawn M. Schmitt

Jun 11, 2024

Essenvia Insights: 8 Expert Tips for Cleaning Up SOPs Before FDA’s QMSR Reg Takes Effect (Part 1 of 2)

FDA

QMSR

Shawn M. Schmitt

Jul 2, 2024

Essenvia Insights: Collisions Are Inevitable at the Crossroads of MedTech Regulation and Device Innovation. Exhibit A: EU’s MDR Fender Bender (Part 2 of 2)

EU

FDA

Shawn M. Schmitt

Jun 24, 2024

Essenvia Insights: ‘Checkpoints’ or ‘Obstacles’? For Device Innovation, MedTech Regulation Can be Friend and Foe (Part 1 of 2)

Regulatory Operations

FDA

Shawn M. Schmitt

Jun 18, 2024

Essenvia Insights: 8 Expert Tips for Cleaning Up SOPs Before FDA’s QMSR Reg Takes Effect (Part 2 of 2)

FDA

QMSR

Shawn M. Schmitt

Jun 11, 2024

Essenvia Insights: 8 Expert Tips for Cleaning Up SOPs Before FDA’s QMSR Reg Takes Effect (Part 1 of 2)

FDA

QMSR

Shawn M. Schmitt

Jul 2, 2024

Essenvia Insights: Collisions Are Inevitable at the Crossroads of MedTech Regulation and Device Innovation. Exhibit A: EU’s MDR Fender Bender (Part 2 of 2)

EU

FDA

Shawn M. Schmitt

Jun 24, 2024

Essenvia Insights: ‘Checkpoints’ or ‘Obstacles’? For Device Innovation, MedTech Regulation Can be Friend and Foe (Part 1 of 2)

Regulatory Operations

FDA

Shawn M. Schmitt

Jun 18, 2024

Essenvia Insights: 8 Expert Tips for Cleaning Up SOPs Before FDA’s QMSR Reg Takes Effect (Part 2 of 2)

FDA

QMSR

Shawn M. Schmitt

Jun 11, 2024

Essenvia Insights: 8 Expert Tips for Cleaning Up SOPs Before FDA’s QMSR Reg Takes Effect (Part 1 of 2)

FDA

QMSR